⌘K

Login Start Free

Home/Filings/4/0001209191-20-036698

4//SEC Filing

Grigoriadis Dimitri E. 4

Accession 0001209191-20-036698

CIK 0000914475other

View on SEC.gov Company Profile

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 5:31 PM ET

Size

14.4 KB

Accession

0001209191-20-036698

Insider Transaction Report

Form 4

Period: 2020-06-11

NEUROCRINE BIOSCIENCES INCNBIX

Grigoriadis Dimitri E.

Vice President, Research

Transactions

Exercise/Conversion
Common Stock
2020-06-11$32.99/sh+2,710$89,403→ 74,702 total
Exercise/Conversion
Common Stock
2020-06-11$43.24/sh+1,049$45,359→ 77,563 total
Exercise/Conversion
Incentive Stock Option
2020-06-11$35.99/sh−1,812$65,214→ 0 total
Exercise: $35.99Exp: 2026-02-05→ Common Stock (1,812 underlying)
Exercise/Conversion
Incentive Stock Option
2020-06-11$32.99/sh−2,710$89,403→ 0 total
Exercise: $32.99Exp: 2025-02-03→ Common Stock (2,710 underlying)
Exercise/Conversion
Common Stock
2020-06-11$35.99/sh+1,812$65,214→ 76,514 total
Exercise/Conversion
Incentive Stock Option
2020-06-11$43.24/sh−1,049$45,359→ 2,151 total
Exercise: $43.24Exp: 2027-02-06→ Common Stock (1,049 underlying)

Footnotes (3)

[F1]Option granted February 3, 2015 and vested monthly over four years.
[F2]Option granted February 5, 2016 and vested monthly over four years.
[F3]Option granted February 6, 2017 and vests monthly over four years.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

NEUROCRINE BIOSCIENCES INC

CIK 0000914475

Entity typeother

Related Parties

1

filerCIK 0001423838

Filing Metadata

Form type: 4
Filed: Jun 14, 8:00 PM ET
Accepted: Jun 15, 5:31 PM ET
Size: 14.4 KB

View on SEC.gov